Danaher Corporation (DHR)
NYSE: DHR · Real-Time Price · USD
210.23
+2.28 (1.10%)
Feb 21, 2025, 4:00 PM EST - Market closed

Danaher Market Cap

Danaher has a market cap or net worth of $151.18 billion as of February 21, 2025. Its market cap has decreased by -17.57% in one year.

Market Cap
151.18B
Enterprise Value
165.10B
1-Year Change
-17.57%
Ranking
Category
Stock Price
$210.23

Market Cap Chart

Since December 1, 1998, Danaher's market cap has increased from $6.13B to $151.18B, an increase of 2,368.02%. That is a compound annual growth rate of 12.99%.

History

DateMarket Cap% Change
Feb 21, 2025150.25B-9.38%
Dec 31, 2024165.80B-3.01%
Dec 29, 2023170.94B-11.53%
Dec 30, 2022193.22B-17.82%
Dec 31, 2021235.10B48.98%
Dec 31, 2020157.80B43.14%
Dec 31, 2019110.24B52.53%
Dec 31, 201872.28B11.94%
Dec 29, 201764.57B19.92%
Dec 30, 201653.84B-15.41%
Dec 31, 201563.65B5.68%
Dec 31, 201460.23B11.90%
Dec 31, 201353.82B39.00%
Dec 31, 201238.72B19.93%
Dec 30, 201132.29B4.66%
Dec 31, 201030.85B27.69%
Dec 31, 200924.16B33.51%
Dec 31, 200818.09B-33.56%
Dec 31, 200727.23B22.14%
Dec 29, 200622.30B29.74%
Dec 30, 200517.19B-3.00%
Dec 31, 200417.72B25.76%
Dec 31, 200314.09B40.70%
Dec 31, 200210.01B16.16%
Dec 31, 20018.62B-11.14%
View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 784.71B
UnitedHealth Group 429.24B
Novo Nordisk 391.83B
Johnson & Johnson 390.76B
AbbVie 356.74B
Abbott Laboratories 234.01B
AstraZeneca 229.50B
Merck & Co. 226.40B
Market Cap Rankings